All of echinacea the active B12 group reporting showed reduction in severity of symptoms ranging from 31% to 70%, while the angustifolia and root placebo controls reported either echinacea no angustifolia change or a root worsening of symptoms. Wilcoxon-Rank of .002 for the end-points of sneezing, echinacea nasal congestion and runny nose; and p = .005 for IgE reductions. In 1992, the above mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. The FDA panel acknowledged the safety of the treatment. The panel seemed to be in agreement that the statistics indicated angustifolia a significant reduction in IgE and that a quantitative drop in symptoms was demonstrated. In 1992, Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge testing. The test was repeated root after premedication with 1.5 mg of oral cyanocobalamin. In four of the five patients echinacea treated, bronchospasm did not develop in the second metabisulfite challenge.6

Genentech and Novartis are developing an anti-IgE monoclonal antibody for asthma and angustifolia allergic rhinitis. In December 1999 they announced positive study results. This is evidence that reducing IgE results in a reduction of symptoms associated root with IgE-mediated echinacea allergic disease.13 angustifolia For people who find they cannot adequately avoid the allergens, the symptoms often can be controlled with medications. Effective medications that can be prescribed by a physician include antihistamines, topical nasal steroids, root and echinacea cromolyn sodium - any of which can be used alone or in combination. angustifolia Many effective antihistamines and decongestants also are available without a prescription. root Click here for allergy medication online.

©2003 www.female-prenatal-supplements.com All rights reserved.